Literature DB >> 22820451

Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor.

Amélie Dufaÿ Wojcicki1, Hervé Hillaireau, Thais Leite Nascimento, Silvia Arpicco, Myriam Taverna, Sandy Ribes, Mickaël Bourge, Valérie Nicolas, Amélie Bochot, Christine Vauthier, Nicolas Tsapis, Elias Fattal.   

Abstract

The mechanism by which hyaluronic acid (HA)-bearing lipoplexes target the A549 lung cancer cell line was evaluated. For this purpose, cationic liposomes targeting the CD44 receptor were designed thanks to the incorporation in their composition of a conjugate between high molecular weight HA and the lipid DOPE (HA-DOPE). Liposomes containing HA-DOPE were complexed at different lipids:DNA ratios with a reporter plasmid encoding the green fluorescent protein (GFP). Diameter, zeta potential, lipoplex stability and DNA protection from nucleases have been determined. Lipids:DNA ratios of 2, 4 and 6 provided a diameter around 250 nm with a zeta potential of -30 mV. The strength of lipids:DNA interaction and the fraction of DNA protected from enzymatic degradation increased with the lipids:DNA ratio. 2D-immunoelectrophoresis demonstrated the low capacity to activate the C3 fraction of the complement system of any of these three ratios, with and without HA-DOPE. Transfection efficiency in the presence of 0, 10 and 15% of HA-DOPE or unconjugated HA, was determined on the CD44-expressing A549 cells by flow cytometry. Lipoplexes at a lipids:DNA ratio of 2 containing 10% (w/w) of HA-DOPE were the most efficient for transfection. The maximal level of GFP expression was obtained after 6h of incubation demonstrating a slow transfection kinetics of lipoplexes. Finally, lipoplex cellular uptake, measured indirectly by the level of transfection using flow cytometry and validated by fluorescence microscopy, was shown to be mediated by the CD44 receptor and caveolae. These results demonstrate the strong specificity of DNA targeting through the CD44 receptor using HA of high molecular weight as a ligand.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820451     DOI: 10.1016/j.jconrel.2012.07.015

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

1.  MZF1 Transcriptionally Activated MicroRNA-328-3p Suppresses the Malignancy of Stomach Adenocarcinoma via Inhibiting CD44.

Authors:  Zining Qi; Jing Wang; Yaoping Li; Yanzhao Xu
Journal:  J Immunol Res       Date:  2022-05-28       Impact factor: 4.493

Review 2.  Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy.

Authors:  Marcela Tavares Luiz; Jessyca Aparecida Paes Dutra; Larissa Bueno Tofani; Jennifer Thayanne Cavalcante de Araújo; Leonardo Delello Di Filippo; Juliana Maldonado Marchetti; Marlus Chorilli
Journal:  Pharmaceutics       Date:  2022-04-08       Impact factor: 6.525

3.  Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery.

Authors:  Xin Zhang; Jiayi Pan; Momei Yao; Livia Palmerston Mendes; Can Sarisozen; Shirui Mao; Vladimir P Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2020-07-06       Impact factor: 5.589

4.  Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells.

Authors:  Hongxin Shen; Sanjun Shi; Zhirong Zhang; Tao Gong; Xun Sun
Journal:  Theranostics       Date:  2015-04-05       Impact factor: 11.556

Review 5.  Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer.

Authors:  Suniti Misra; Vincent C Hascall; Roger R Markwald; Shibnath Ghatak
Journal:  Front Immunol       Date:  2015-05-06       Impact factor: 7.561

Review 6.  Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.

Authors:  Sabrina Valetti; Simona Mura; Barbara Stella; Patrick Couvreur
Journal:  J Nanobiotechnology       Date:  2013-12-10       Impact factor: 10.435

7.  Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells.

Authors:  Silvia Arpicco; Giuseppe De Rosa; Elias Fattal
Journal:  J Drug Deliv       Date:  2013-03-07

Review 8.  Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery.

Authors:  Suniti Misra; Vincent C Hascall; Ilia Atanelishvili; Ricardo Moreno Rodriguez; Roger R Markwald; Shibnath Ghatak
Journal:  Int J Cell Biol       Date:  2015-09-10

9.  Chemoenzymatic synthesis of oligohyaluronan-lipid conjugates.

Authors:  Dipali Ruhela; Saul Kivimäe; Francis C Szoka
Journal:  Bioconjug Chem       Date:  2014-03-28       Impact factor: 4.774

10.  Increased tumor distribution and expression of histidine-rich plasmid polyplexes.

Authors:  Qixin Leng; Szu-Ting Chou; Puthupparampil V Scaria; Martin C Woodle; A James Mixson
Journal:  J Gene Med       Date:  2014 Sep-Oct       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.